vs

Side-by-side financial comparison of Hilltop Holdings Inc. (HTH) and INSMED Inc (INSM). Click either name above to swap in a different company.

Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $263.8M, roughly 1.1× INSMED Inc). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs -124.5%, a 137.5% gap on every dollar of revenue. Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs 0.6%).

Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

HTH vs INSM — Head-to-Head

Bigger by revenue
HTH
HTH
1.1× larger
HTH
$300.5M
$263.8M
INSM
Higher net margin
HTH
HTH
137.5% more per $
HTH
13.0%
-124.5%
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
0.6%
HTH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
HTH
HTH
INSM
INSM
Revenue
$300.5M
$263.8M
Net Profit
$39.0M
$-328.5M
Gross Margin
83.2%
Operating Margin
-121.2%
Net Margin
13.0%
-124.5%
Revenue YoY
152.6%
Net Profit YoY
-12.4%
-39.5%
EPS (diluted)
$0.64
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTH
HTH
INSM
INSM
Q1 26
$300.5M
Q4 25
$329.9M
$263.8M
Q3 25
$330.2M
$142.3M
Q2 25
$303.3M
$107.4M
Q1 25
$318.5M
$92.8M
Q4 24
$301.1M
$104.4M
Q3 24
$305.5M
$93.4M
Q2 24
$297.0M
$90.3M
Net Profit
HTH
HTH
INSM
INSM
Q1 26
$39.0M
Q4 25
$41.6M
$-328.5M
Q3 25
$45.8M
$-370.0M
Q2 25
$36.1M
$-321.7M
Q1 25
$42.1M
$-256.6M
Q4 24
$35.5M
$-235.5M
Q3 24
$29.7M
$-220.5M
Q2 24
$20.3M
$-300.6M
Gross Margin
HTH
HTH
INSM
INSM
Q1 26
Q4 25
83.2%
Q3 25
79.4%
Q2 25
73.9%
Q1 25
77.1%
Q4 24
75.0%
Q3 24
77.3%
Q2 24
76.8%
Operating Margin
HTH
HTH
INSM
INSM
Q1 26
Q4 25
16.1%
-121.2%
Q3 25
18.4%
-257.1%
Q2 25
16.3%
-291.3%
Q1 25
18.1%
-267.3%
Q4 24
14.7%
-220.6%
Q3 24
13.9%
-228.4%
Q2 24
10.0%
-319.8%
Net Margin
HTH
HTH
INSM
INSM
Q1 26
13.0%
Q4 25
12.6%
-124.5%
Q3 25
13.9%
-260.0%
Q2 25
11.9%
-299.5%
Q1 25
13.2%
-276.4%
Q4 24
11.8%
-225.5%
Q3 24
9.7%
-236.0%
Q2 24
6.8%
-332.8%
EPS (diluted)
HTH
HTH
INSM
INSM
Q1 26
$0.64
Q4 25
$0.68
$-1.55
Q3 25
$0.74
$-1.75
Q2 25
$0.57
$-1.70
Q1 25
$0.65
$-1.42
Q4 24
$0.55
$-1.30
Q3 24
$0.46
$-1.27
Q2 24
$0.31
$-1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTH
HTH
INSM
INSM
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$990.8M
$546.8M
Stockholders' EquityBook value
$2.2B
$739.0M
Total Assets
$15.7B
$2.3B
Debt / EquityLower = less leverage
0.46×
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTH
HTH
INSM
INSM
Q1 26
Q4 25
$1.4B
Q3 25
$1.7B
Q2 25
$1.9B
Q1 25
$1.2B
Q4 24
$1.4B
Q3 24
$1.5B
Q2 24
$1.2B
Total Debt
HTH
HTH
INSM
INSM
Q1 26
$990.8M
Q4 25
$546.8M
Q3 25
$546.8M
Q2 25
$546.8M
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$971.8M
Q2 24
$1.2B
Stockholders' Equity
HTH
HTH
INSM
INSM
Q1 26
$2.2B
Q4 25
$2.2B
$739.0M
Q3 25
$2.2B
$945.6M
Q2 25
$2.2B
$1.2B
Q1 25
$2.2B
$99.2M
Q4 24
$2.2B
$285.4M
Q3 24
$2.2B
$483.4M
Q2 24
$2.1B
$38.8M
Total Assets
HTH
HTH
INSM
INSM
Q1 26
$15.7B
Q4 25
$15.8B
$2.3B
Q3 25
$15.6B
$2.4B
Q2 25
$15.4B
$2.5B
Q1 25
$15.8B
$1.8B
Q4 24
$16.3B
$2.0B
Q3 24
$15.9B
$2.1B
Q2 24
$15.6B
$1.8B
Debt / Equity
HTH
HTH
INSM
INSM
Q1 26
0.46×
Q4 25
0.74×
Q3 25
0.58×
Q2 25
0.44×
Q1 25
11.31×
Q4 24
3.93×
Q3 24
2.01×
Q2 24
30.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTH
HTH
INSM
INSM
Operating Cash FlowLast quarter
$-247.6M
Free Cash FlowOCF − Capex
$-264.2M
FCF MarginFCF / Revenue
-100.1%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTH
HTH
INSM
INSM
Q1 26
Q4 25
$-38.7M
$-247.6M
Q3 25
$273.0M
$-219.8M
Q2 25
$-234.6M
$-205.6M
Q1 25
$5.8M
$-262.1M
Q4 24
$273.9M
$-196.0M
Q3 24
$515.6M
$-180.9M
Q2 24
$-435.3M
$-123.0M
Free Cash Flow
HTH
HTH
INSM
INSM
Q1 26
Q4 25
$-55.5M
$-264.2M
Q3 25
$271.0M
$-222.2M
Q2 25
$-234.6M
$-209.1M
Q1 25
$5.0M
$-272.2M
Q4 24
$266.8M
$-202.8M
Q3 24
$513.8M
$-184.6M
Q2 24
$-437.3M
$-129.7M
FCF Margin
HTH
HTH
INSM
INSM
Q1 26
Q4 25
-16.8%
-100.1%
Q3 25
82.1%
-156.1%
Q2 25
-77.4%
-194.6%
Q1 25
1.6%
-293.2%
Q4 24
88.6%
-194.1%
Q3 24
168.2%
-197.6%
Q2 24
-147.2%
-143.6%
Capex Intensity
HTH
HTH
INSM
INSM
Q1 26
Q4 25
5.1%
6.3%
Q3 25
0.6%
1.7%
Q2 25
0.0%
3.2%
Q1 25
0.3%
10.8%
Q4 24
2.4%
6.5%
Q3 24
0.6%
3.9%
Q2 24
0.7%
7.5%
Cash Conversion
HTH
HTH
INSM
INSM
Q1 26
Q4 25
-0.93×
Q3 25
5.96×
Q2 25
-6.50×
Q1 25
0.14×
Q4 24
7.71×
Q3 24
17.36×
Q2 24
-21.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HTH
HTH

Noninterest Income$188.4M63%
Net Interest Income$112.1M37%

INSM
INSM

Segment breakdown not available.

Related Comparisons